Bio-Rad Laboratories, Inc. (BIO)
381.07
+1.04
(+0.27%)
USD |
NYSE |
Aug 24, 16:00
381.07
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Net Income (Quarterly) : 371.40M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 371.40M |
| March 31, 2026 | -527.10M |
| December 31, 2025 | 720.00M |
| September 30, 2025 | -341.90M |
| June 30, 2025 | 317.80M |
| March 31, 2025 | 64.00M |
| December 31, 2024 | -715.80M |
| September 30, 2024 | 653.17M |
| June 30, 2024 | -2.165B |
| March 31, 2024 | 383.92M |
| December 31, 2023 | 349.71M |
| September 30, 2023 | 106.26M |
| June 30, 2023 | -1.162B |
| March 31, 2023 | 68.96M |
| December 31, 2022 | 827.73M |
| September 30, 2022 | -162.81M |
| June 30, 2022 | -925.11M |
| March 31, 2022 | -3.367B |
| December 31, 2021 | -1.572B |
| September 30, 2021 | 3.928B |
| June 30, 2021 | 914.11M |
| March 31, 2021 | 977.41M |
| December 31, 2020 | 839.10M |
| September 30, 2020 | 1.315B |
| June 30, 2020 | 966.43M |
| Date | Value |
|---|---|
| March 31, 2020 | 685.91M |
| December 31, 2019 | 553.49M |
| September 30, 2019 | -258.82M |
| June 30, 2019 | 598.81M |
| March 31, 2019 | 865.20M |
| December 31, 2018 | -833.15M |
| September 30, 2018 | 269.33M |
| June 30, 2018 | 268.04M |
| March 31, 2018 | 656.77M |
| December 31, 2017 | 82.73M |
| September 30, 2017 | 22.07M |
| June 30, 2017 | 5.035M |
| March 31, 2017 | 12.41M |
| December 31, 2016 | -20.57M |
| September 30, 2016 | 18.40M |
| June 30, 2016 | 18.01M |
| March 31, 2016 | 12.28M |
| December 31, 2015 | 49.48M |
| September 30, 2015 | 17.37M |
| June 30, 2015 | 28.42M |
| March 31, 2015 | 17.82M |
| December 31, 2014 | 39.04M |
| September 30, 2014 | 11.51M |
| June 30, 2014 | 31.63M |
| March 31, 2014 | 6.668M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.742B |
| Agilent Technologies, Inc. | 339.00M |
| Danaher Corp. | 870.00M |
| Illumina, Inc. | 207.00M |
| Revvity, Inc. | 53.48M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 651.00M |
| Total Expenses (Quarterly) | 279.60M |
| EPS Diluted (Quarterly) | 13.85 |
| Enterprise Value | 9.912B |
| Gross Profit Margin (Quarterly) | 53.12% |
| Profit Margin (Quarterly) | 57.05% |
| Earnings Yield | 2.17% |
| Operating Earnings Yield | 2.29% |
| Normalized Earnings Yield | 1.683 |